American journal of physiology. Heart and circulatory physiologyJournal Article
09 May 2025
Chronic heart failure (CHF) involves skeletal muscle abnormalities, including atrophy, inflammation, mitochondrial dysfunction, and fibrosis, which impair contractile function. This study examines whether muscle deterioration correlates with CHF disease severity by assessing the relationship between circulating N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) concentrations, left ventricular ejection fraction (LVEF), and muscle characteristics in CHF patients. In 36 patients with CHF (LVEF≤45%, NYHA class I-III), we measured circulating NT-proBNP concentrations, LVEF, muscle strength and functional measures, and myocellular features, including fiber type-specific cross-sectional area (CSA), muscle stem cell (MuSC) and myonuclei content, and capillary density. Also, muscle mitochondrial function was evaluated. The concentration of NT-proBNP inversely correlated with muscle strength (R=0.25, P<0.01), mean fiber CSA (R=0.15, P=0.04), and MuSC content (R=0.37, P<0.01). Moreover, a non-significant inverse correlation was observed for capillary density (R=0.12, P=0.06). The strength of associations between NT-proBNP, fiber CSA and capillary density was primarily driven by fiber type-specific correlations. Associations to MuSC content was equally strong across fiber types. No corelation was observed for measures of mitochondrial function. For LVEF, a non-significant correlation was observed only for overall MuSC content (R=0.11 P=0.07). Skeletal muscle deterioration in patients with CHF correlates with NT-proBNP, but not LVEF, suggesting that NT-proBNP concentration constitutes a stronger indicator of the link between CHF severity and skeletal muscle decline than LVEF as function parameter. Our findings highlights circulating NTpro-BNP concentrations as a potential biomarker for identification of patients at risk of experiencing skeletal muscle deterioration.
Share: